We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNOX icon
3551
Nano X Imaging
NNOX
$50.3M
$20.1K ﹤0.01%
17,371
+10,967
+171% +$20.6K
MNTN
3552
MNTN Inc
MNTN
$824M
$20.1K ﹤0.01%
+2,189
New +$19.9K
ROOT icon
3553
Root
ROOT
$734M
$20.1K ﹤0.01%
360
-779
-68% -$41.6K
KRT icon
3554
Karat Packaging
KRT
$1.06B
$20.1K ﹤0.01%
600
+136
+29% +$3.92K
KWY
3555
Kingsway Corp
KWY
$261M
$20K ﹤0.01%
1,920
-2,498
-57% -$26.9K
ITUB icon
3556
Itaú Unibanco
ITUB
$89.4B
$20K ﹤0.01%
+2,448
New +$20.3K
POWA icon
3557
Invesco Bloomberg Pricing Power ETF
POWA
$166M
$20K ﹤0.01%
225
-3,765
-94% -$330K
PDYN icon
3558
Palladyne AI
PDYN
$266M
$20K ﹤0.01%
3,286
-1,216
-27% -$8.05K
XOMA
3559
DELISTED
Xoma
XOMA
$20K ﹤0.01%
470
-102
-18% -$4.14K
ZURA icon
3560
Zura Bio
ZURA
$387M
$20K ﹤0.01%
+3,383
New +$16.1K
STXS icon
3561
Stereotaxis
STXS
$130M
$19.9K ﹤0.01%
11,593
-565
-5% -$1.06K
DRN icon
3562
Direxion Daily Real Estate Bull 3X ETF
DRN
$36.1M
$19.9K ﹤0.01%
1,887
+699
+59% +$7.37K
BLND icon
3563
Blend Labs
BLND
$263M
$19.9K ﹤0.01%
11,608
-10,630
-48% -$17K
RCMT icon
3564
RCM Technologies
RCMT
$288M
$19.8K ﹤0.01%
701
-261
-27% -$7K
TTGT icon
3565
TechTarget
TTGT
$277M
$19.8K ﹤0.01%
5,497
+2,671
+95% +$12.2K
OABI icon
3566
OmniAb
OABI
$670M
$19.8K ﹤0.01%
8,044
-27,262
-77% -$54.1K
STRW icon
3567
Strawberry Fields REIT
STRW
$190M
$19.8K ﹤0.01%
1,438
-1,298
-47% -$16.9K
KVHI icon
3568
KVH Industries
KVHI
$134M
$19.7K ﹤0.01%
+1,992
New +$19.1K
HVT icon
3569
Haverty Furniture Companies
HVT
$436M
$19.7K ﹤0.01%
773
-1,223
-61% -$27.7K
SMTI icon
3570
Sanara MedTech
SMTI
$322M
$19.7K ﹤0.01%
835
-66
-7% -$1.36K
ADCT icon
3571
ADC Therapeutics
ADCT
$162M
$19.6K ﹤0.01%
18,361
+10,369
+130% +$30.2K
VIRC icon
3572
Virco
VIRC
$102M
$19.6K ﹤0.01%
3,195
-1,501
-32% -$9.11K
BH icon
3573
Biglari Holdings Class B
BH
$1.1B
$19.6K ﹤0.01%
46
-26
-36% -$8.12K
ACHV icon
3574
Achieve Life Sciences
ACHV
$776M
$19.6K ﹤0.01%
+2,994
New +$14.3K
ARVN icon
3575
Arvinas
ARVN
$496M
$19.5K ﹤0.01%
2,351
-684
-23% -$6.38K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.